Type: therapy
Status: Emerging Strategy
Developer: Multiple Research Institutions / Collaborative
A novel approach that doesn't just replace beta cells but retrains the immune system. By combining regulatory T-cell (Treg) therapy with encapsulated stem cell-derived islets, researchers aim to stop the autoimmune attack responsible for Type 1 diabetes. This 'bold plan' could eliminate the need for toxic immunosuppressive drugs, offering a true biological cure rather than just a treatment.
This therapy works on two fronts: 1) It introduces healthy, insulin-producing islet cells derived from stem cells to restore blood sugar control. 2) Simultaneously, it uses expanded regulatory T-cells to 'teach' the patient's immune system to tolerate these new cells, preventing rejection without lifelong drugs.
Year: 2026